Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-2 of 2
Keywords: (−)-epigallocatechin-3-gallate (EGCG)
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2014) 126 (9): 631–632.
Published: 14 January 2014
... Journal compilation © 2014 Biochemical Society 2014 (−)-epigallocatechin-3-gallate (EGCG) angiogenesis green tea polyphenol (GTP) liver cirrhosis portosystemic collateral Cirrhosis, and its main complication PH (portal hypertension), represents a leading cause of mortality worldwide...
Articles
Shao-Jung Hsu, Sun-Sang Wang, I-Fang Hsin, Fa-Yauh Lee, Hui-Chun Huang, Teh-Ia Huo, Wen-Shin Lee, Han-Chieh Lin, Shou-Dong Lee
Journal:
Clinical Science
Clin Sci (Lond) (2014) 126 (9): 633–644.
Published: 14 January 2014
...-related complications via anti-angiogenenic effects. (−)-epigallocatechin-3-gallate (EGCG) angiogenesis green tea polyphenol (GTP) liver cirrhosis portosystemic collateral • Angiogenesis participates in portal hypertension and porto-systemic collateral formation in liver cirrhosis...
